Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies-Reference-Cited by-同舟云学术

Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies

Published:2013-05-17 Issue:13 Volume:19 Page:3681-3692
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Brauer Matthew J.,Zhuang Guanglei,Schmidt Maike,Yao Jenny,Wu Xiumin,Kaminker Joshua S.,Jurinka Stefanie S.,Kolumam Ganesh,Chung Alicia S.,Jubb Adrian,Modrusan Zora,Ozawa Tomoko,James C. David,Phillips Heidi,Haley Benjamin,Tam Rachel N.W.,Clermont Anne C.,Cheng Jason H.,Yang Sherry X.,Swain Sandra M.,Chen Daniel,Scherer Stefan J.,Koeppen Hartmut,Yeh Ru-Fang,Yue Peng,Stephan Jean-Philippe,Hegde Priti,Ferrara Napoleone,Singh Mallika,Bais Carlos

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-28A/IL-10Rβ axis promotes angiogenesis via eNOS/AKT signaling and AP-1/NF-κB/MMP-2 network by regulating HSP70-1 expression;Journal of Advanced Research;2024-08

2. Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial;Nature Communications;2023-08-14

3. Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma;Cancer Drug Resistance;2023-08-02

4. Histopathological subtyping of high-grade serous ovarian cancer using whole slide imaging;Journal of Gynecologic Oncology;2023

5. Optimization of first‐line systemic therapy in patients with advanced clear cell renal cell carcinoma;International Journal of Urology;2022-12-07